Not all patients with CLL involve therapy. In spite of all latest improvements, the iwCLL nonetheless suggests watchful observation for patients with asymptomatic illness.86 This recommendation is based on no less than two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trials concluded https://jamesw864ven3.activoblog.com/profile